BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25554695)

  • 1. Proteome screening of pleural effusions identifies IL1A as a diagnostic biomarker for non-small cell lung cancer.
    Li Y; Lian H; Jia Q; Wan Y
    Biochem Biophys Res Commun; 2015 Feb; 457(2):177-82. PubMed ID: 25554695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of retinoblastoma-associated binding protein 46 as a novel prognostic marker for distant metastasis in nonsmall cell lung cancer by combined analysis of cancer cell secretome and pleural effusion proteome.
    Wang CL; Wang CI; Liao PC; Chen CD; Liang Y; Chuang WY; Tsai YH; Chen HC; Chang YS; Yu JS; Wu CC; Yu CJ
    J Proteome Res; 2009 Oct; 8(10):4428-40. PubMed ID: 19655816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteome screening of pleural effusions identifies galectin 1 as a diagnostic biomarker and highlights several prognostic biomarkers for malignant mesothelioma.
    Mundt F; Johansson HJ; Forshed J; Arslan S; Metintas M; Dobra K; Lehtiö J; Hjerpe A
    Mol Cell Proteomics; 2014 Mar; 13(3):701-15. PubMed ID: 24361865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the identification of biomarkers for non-small cell lung cancer in serum and pleural effusion.
    Rodríguez-Piñeiro AM; Blanco-Prieto S; Sánchez-Otero N; Rodríguez-Berrocal FJ; de la Cadena MP
    J Proteomics; 2010 Jun; 73(8):1511-22. PubMed ID: 20230924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of F-18 FDG PET/CT for malignant pleural effusion in non-small cell lung cancer patients.
    Kim BS; Kim IJ; Kim SJ; Pak K; Kim K
    Onkologie; 2011; 34(6):298-303. PubMed ID: 21625182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of proteins isolated from microvesicles derived from human lung cancer pleural effusions.
    Park JO; Choi DY; Choi DS; Kim HJ; Kang JW; Jung JH; Lee JH; Kim J; Freeman MR; Lee KY; Gho YS; Kim KP
    Proteomics; 2013 Jul; 13(14):2125-34. PubMed ID: 23585444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive proteome analysis of malignant pleural effusion for lung cancer biomarker discovery by using multidimensional protein identification technology.
    Yu CJ; Wang CL; Wang CI; Chen CD; Dan YM; Wu CC; Wu YC; Lee IN; Tsai YH; Chang YS; Yu JS
    J Proteome Res; 2011 Oct; 10(10):4671-82. PubMed ID: 21806062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic value of apolipoprotein E in malignant pleural effusion associated with non-small cell lung cancer.
    Wang Y; Chen Z; Chen J; Pan J; Zhang W; Pan Q; Ding H; Lin X; Wen X; Li Y; Meng QH
    Clin Chim Acta; 2013 Jun; 421():230-5. PubMed ID: 23523589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of HER-2/neu protein in malignant pleural effusion-associated lung adenocarcinoma and as a tumor marker in pleural effusion diagnosis.
    Hung TL; Chen FF; Liu JM; Lai WW; Hsiao AL; Huang WT; Chen HH; Su WC
    Clin Cancer Res; 2003 Jul; 9(7):2605-12. PubMed ID: 12855637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
    Klech H; Rona G; Hutter C; Bayer PM; Kummer F
    Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic values of endothelial-cell-specific molecule-1 with malignant pleural effusions in patients with non-small cell lung cancer.
    Lu GJ; Shao CJ; Zhang Y; Wei YY; Xie WP; Kong H
    Oncotarget; 2017 Jul; 8(30):49217-49223. PubMed ID: 28514746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic profiling of human pleural effusion using two-dimensional nano liquid chromatography tandem mass spectrometry.
    Tyan YC; Wu HY; Lai WW; Su WC; Liao PC
    J Proteome Res; 2005; 4(4):1274-86. PubMed ID: 16083277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotrophin system activation in pleural effusions.
    Ricci A; Mariotta S; Pompili E; Mancini R; Bronzetti E; De Vitis C; Pisani L; Cherubini E; Bruno P; Gencarelli G; Giovagnoli MR; Terzano C; Ciliberto G; Giarnieri E; Fumagalli L
    Growth Factors; 2010 Aug; 28(4):221-31. PubMed ID: 20214505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-depth proteomic analysis of six types of exudative pleural effusions for nonsmall cell lung cancer biomarker discovery.
    Liu PJ; Chen CD; Wang CL; Wu YC; Hsu CW; Lee CW; Huang LH; Yu JS; Chang YS; Wu CC; Yu CJ
    Mol Cell Proteomics; 2015 Apr; 14(4):917-32. PubMed ID: 25638566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of pleural effusion in patients with non-small cell lung cancer.
    Sugiura S; Ando Y; Minami H; Ando M; Sakai S; Shimokata K
    Clin Cancer Res; 1997 Jan; 3(1):47-50. PubMed ID: 9815536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of differentially expressed proteins in human malignant pleural effusions.
    Hsieh WY; Chen MW; Ho HT; You TM; Lu YT
    Eur Respir J; 2006 Dec; 28(6):1178-85. PubMed ID: 16899477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenetic biomarkers in non-small cell lung cancer with malignant pleural effusion: correlations with patient survival and pleural effusion control.
    Hsu IL; Su WC; Yan JJ; Chang JM; Lai WW
    Lung Cancer; 2009 Sep; 65(3):371-6. PubMed ID: 19157636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-glycoprotein profiling of lung adenocarcinoma pleural effusions by shotgun proteomics.
    Soltermann A; Ossola R; Kilgus-Hawelski S; von Eckardstein A; Suter T; Aebersold R; Moch H
    Cancer; 2008 Apr; 114(2):124-33. PubMed ID: 18327805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and comparison of EGFR mutations in matched tumor tissues, cell blocks, pleural effusions, and sera from patients with NSCLC with malignant pleural effusion, by PNA clamping and direct sequencing.
    Yeo CD; Kim JW; Kim KH; Ha JH; Rhee CK; Kim SJ; Kim YK; Park CK; Lee SH; Park MS; Yim HW
    Lung Cancer; 2013 Aug; 81(2):207-12. PubMed ID: 23726527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The reactivity to CK5/6 antibody in tumor cells from non-small cell lung cancers shed into pleural effusions predicts survival.
    Dejmek JS; Dejmek A
    Oncol Rep; 2006 Mar; 15(3):583-7. PubMed ID: 16465416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.